NCT07030348View on ClinicalTrials.gov

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

RecruitingOBSERVATIONAL
Enrollment

263

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pancreatic CancersPancreatic Diseases
Trial Locations (3)

44195

RECRUITING

Cleveland Clinic, Cleveland

80045

RECRUITING

University of Colorado Hospital, Aurora

05505

RECRUITING

Asan Medical Center, Seoul

All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

collaborator

University of Colorado, Denver

OTHER

lead

Do Hyun Park

OTHER

NCT07030348 - Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study | Biotech Hunter | Biotech Hunter